Scholarlink

Background <p>Maternal per- and polyfluoroalkyl substances (PFAS) exposure has been linked to adverse health effects on offspring, but the mechanisms remain unclear. The present study investigates the relationship between maternal PFAS exposure and the expression of placental cytochrome P450 enzymes (CYP19A1, CYP2J2, and CYP2E1), and explores the potential role of these enzymes in linking maternal PFAS exposure to offspring development.</p> Methods <p>We included 350 mother-infant pairs from the Jiashan birth cohort. Thirteen PFAS compounds were measured in maternal plasma collected at 8–16&#xa0;weeks of gestation, while the expression levels of the three CYP genes were quantified in placental tissues collected at delivery. Offspring weight and length were measured at birth and at 1, 3, 6, 8, 12, and 24&#xa0;months of age, and their ponderal index (PI) was computed. Multivariable linear regression was used to examine associations between plasma concentrations of individual PFAS and placental CYP gene expression. Quantile-based g-computation was used to examine the association of the PFAS mixture with placental CYP gene expression. A linear mixed model was used to examine the associations of maternal PFAS and placental CYP expression levels with repeated PI measurements from birth to 24&#xa0;months. Multilevel mediation analysis was conducted to explore the potential mediating role of CYP genes.</p> Results <p>Consistent inverse associations between maternal PFAS exposure and the three placental CYP genes expression in female placentas were observed. Specifically, statistically significant decreases were observed in the associations between all PFAS compounds and CYP2J2 expression with β- estimates for the highest exposure versus the lowest from -0.255 to -0.174, as well as between the highest exposure of perfluorotridecanoic acid (PFTrDA) and CYP19A1 expression (<i>β</i> = -0.279, <i>95% CI</i>: -0.55, -0.007). In contrast, for male fetuses, significant associations were found between the highest exposure of perfluorohexane sulfonate (PFHxS) and increased <i>CYP19A1</i> expression (<i>β</i> = 0.404, <i>95%CI</i>: 0.131,0.677), and between the middle of perfluoroundecanoic acid (PFUdA), perfluorododecanoic acid (PFDoA), PFTrDA, and perfluoroheptanoic acid (PFHPA) and decreased <i>CYP2E1</i> expression (<i>β</i><sub>PFUdA</sub> = -0.286, 95% CI: -0.511,-0.061; <i>β</i><sub>PFDoA</sub> = -0.270, 95% CI: -0.495,-0.045;<i>β</i><sub>PFTrDA</sub> = -0.236, 95% CI: -0.466,-0.006; and <i>β</i><sub>PFHpA</sub> = -0.344, 95% CI: -0.571,-0.117, respectively). The PFAS mixture was associated with decreased the three CYP genes expression in the placenta of female fetuses, but no association was observed in male placentas. Additionally, placental <i>CYP19A1</i> expression was associated with a decrease in girls' PI and an increase in boys' PI, respectively. However, no mediating role of CYP19A1 in the relationship between PFTrDA and PI in girls or between PFHxS and PI in boys was observed, as the indirect effect was not statistically significant.</p> Conclusions <p>These results indicate that maternal PFAS exposure may disrupt placental CYP expression and the implications of these disruptions for offspring development warrant further investigation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Placental CYP450 gene dysregulation by maternal PFAS: a novel mechanism linking prenatal exposure to altered toddler growth

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月2日

查看全文
  • Xiuxia Song,
  • Zhaofeng Zhang,
  • Xiaoyu Zhou,
  • Hong Liang,
  • Yao Chen,
  • Weiqiang Zhu,
  • Wei Yuan,
  • Jing Du,
  • Ziliang Wang,
  • Maohua Miao

摘要

Background

Maternal per- and polyfluoroalkyl substances (PFAS) exposure has been linked to adverse health effects on offspring, but the mechanisms remain unclear. The present study investigates the relationship between maternal PFAS exposure and the expression of placental cytochrome P450 enzymes (CYP19A1, CYP2J2, and CYP2E1), and explores the potential role of these enzymes in linking maternal PFAS exposure to offspring development.

Methods

We included 350 mother-infant pairs from the Jiashan birth cohort. Thirteen PFAS compounds were measured in maternal plasma collected at 8–16 weeks of gestation, while the expression levels of the three CYP genes were quantified in placental tissues collected at delivery. Offspring weight and length were measured at birth and at 1, 3, 6, 8, 12, and 24 months of age, and their ponderal index (PI) was computed. Multivariable linear regression was used to examine associations between plasma concentrations of individual PFAS and placental CYP gene expression. Quantile-based g-computation was used to examine the association of the PFAS mixture with placental CYP gene expression. A linear mixed model was used to examine the associations of maternal PFAS and placental CYP expression levels with repeated PI measurements from birth to 24 months. Multilevel mediation analysis was conducted to explore the potential mediating role of CYP genes.

Results

Consistent inverse associations between maternal PFAS exposure and the three placental CYP genes expression in female placentas were observed. Specifically, statistically significant decreases were observed in the associations between all PFAS compounds and CYP2J2 expression with β- estimates for the highest exposure versus the lowest from -0.255 to -0.174, as well as between the highest exposure of perfluorotridecanoic acid (PFTrDA) and CYP19A1 expression (β = -0.279, 95% CI: -0.55, -0.007). In contrast, for male fetuses, significant associations were found between the highest exposure of perfluorohexane sulfonate (PFHxS) and increased CYP19A1 expression (β = 0.404, 95%CI: 0.131,0.677), and between the middle of perfluoroundecanoic acid (PFUdA), perfluorododecanoic acid (PFDoA), PFTrDA, and perfluoroheptanoic acid (PFHPA) and decreased CYP2E1 expression (βPFUdA = -0.286, 95% CI: -0.511,-0.061; βPFDoA = -0.270, 95% CI: -0.495,-0.045;βPFTrDA = -0.236, 95% CI: -0.466,-0.006; and βPFHpA = -0.344, 95% CI: -0.571,-0.117, respectively). The PFAS mixture was associated with decreased the three CYP genes expression in the placenta of female fetuses, but no association was observed in male placentas. Additionally, placental CYP19A1 expression was associated with a decrease in girls' PI and an increase in boys' PI, respectively. However, no mediating role of CYP19A1 in the relationship between PFTrDA and PI in girls or between PFHxS and PI in boys was observed, as the indirect effect was not statistically significant.

Conclusions

These results indicate that maternal PFAS exposure may disrupt placental CYP expression and the implications of these disruptions for offspring development warrant further investigation.